Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, July 8, 2009

GTC lands Merrimack Pharma’s rights to goat-derived protein

By Craig M. Douglas

GTC Biotherapeutics Inc., a developer of drug therapies derived from animal proteins, has acquired the rights to develop and sell a combination of potential auto-immune treatments discovered by Cambridge-based Merrimack Pharmaceuticals Inc.

Based in Framingham, GTC will return all of its holdings of Merrimack’s Series C convertible stock and will pay Merrimack milestone and royalty payments, depending on the success of its recombinant human alpha-fetoprotein.

In return, GTC will also receive Merrimack’s inventory of the substance, which is derived from transgenic goats, that is suitable for clinical trials.

In June, GTC (Nasdaq: GTCBD) received its second delisting notice in three months from the Nasdaq Stock Market due to the company’s failure to maintain a minimum value threshold of $35 million for its publicly traded common stock.

That notice gave the company 90 days to regain compliance.

GTC booked $16.7 million in revenue and a net loss of $22.7 million in 2008.
 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Bill Gates, Ray Ozzie, Microsoft execs patent 'personal data mining'

By Todd Bishop TechFlash Bill Gates, Ray Ozzie and a bunch of other heavy-hitters from Microsoft are named as inventors on a newly issued patent for a "personal data mining" system that would analyze information and make recommendations with the goal of aiding a person's decisions and improving quality of life. The patent was issued this week, based on a September 2006 patent application. I...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio